Taihill Venture

Bot Auto is a L4 autonomous trucking company, based in Houston, Texas. Operating an autonomous truck fleet and offer Transportation as a Service (TaaS) to freight customers. The team combines visionary leadership, top-tier science and engineering talents, financial and governance experts, and industry veterans to build an AI-driven autonomous trucking company. Bot Auto focused on fleet operations, transforming autonomous trucking into a commercially profitable product. This blend of experience, industry maturity, and innovative technology positions the company to commercialize autonomous trucking at scale.

Kano Therapeutics specializes in advancing gene-editing therapies through the development of innovative biomaterials. The company utilizes circular single-stranded DNA biomaterials to create a comprehensive platform that integrates manufacturing, application, and computational tools for genetic payload development. By harnessing DNA nanotechnology and synthetic biology, Kano Therapeutics designs and engineers novel gene vectors that facilitate the safe and effective delivery of genetic information. This platform supports researchers and organizations in their pursuit of genetic cures and enhances the capabilities of pharmaceutical and synthetic biology companies in gene delivery and vaccine development.

dappOS is a company focused on improving the usability and accessibility of decentralized applications (dApps) and blockchain technology. It develops an operating protocol that simplifies interactions between users and various crypto infrastructures, including public blockchains and cross-chain bridges. By creating intuitive user interfaces and streamlining the user experience, dappOS aims to make dApps as user-friendly as mobile applications. The company's goal is to lower technical barriers, enabling a wider audience to engage with decentralized applications and facilitating mass adoption within a more interconnected blockchain ecosystem.

We develop advanced AI inference technology that consumes only 1/10 the energy of existing solutions, enabling more sustainable and cost-effective artificial intelligence applications

HopeAI is dedicated to improving patient outcomes by accelerating the clinical development of new treatments through artificial intelligence. The company has developed a clinical trial AI research platform designed to make clinical trial results easily accessible and to enhance the efficiency of trial processes. This platform organizes data using natural language, simulates trials to identify potential risks, and employs advanced algorithms to assess patients' responses to treatments in real-time. By integrating an AI copilot with current clinical evidence and statistical insights, HopeAI aims to support clinical development teams in making informed decisions that increase the likelihood of success and reduce the time required to bring new therapies to market. The ultimate goal is to enable the rapid testing of promising drug candidates in AI-enhanced clinical trials, ensuring that life-saving medicines reach patients in need more swiftly.

dappOS is a company focused on improving the usability and accessibility of decentralized applications (dApps) and blockchain technology. It develops an operating protocol that simplifies interactions between users and various crypto infrastructures, including public blockchains and cross-chain bridges. By creating intuitive user interfaces and streamlining the user experience, dappOS aims to make dApps as user-friendly as mobile applications. The company's goal is to lower technical barriers, enabling a wider audience to engage with decentralized applications and facilitating mass adoption within a more interconnected blockchain ecosystem.

Collov is a software-as-a-service (SaaS) company that offers a virtual interior design and shopping platform aimed at enhancing spatial intelligence. The platform utilizes artificial intelligence and virtual reality technologies to transform living spaces, providing users with an interactive interior design experience. Through its AI algorithm-driven e-commerce platform, Collov delivers tailored home decoration solutions, allowing clients to present a diverse range of interior design options to homeowners. This innovative approach enables individuals to visualize and implement their desired home aesthetics effectively.

Perceptive is focused on the design, development, and manufacturing of medical devices specifically for the dentistry sector. The company has pioneered automated robotics technology that aims to revolutionize dental care by establishing image-guided robotic restorative dentistry as a standard practice. This innovative technology enhances the precision with which dentists can identify and eliminate tooth decay, ultimately delivering superior restorations to patients more efficiently and at a reduced cost. By leveraging advanced techniques, Perceptive enhances clinical capacity and aims to improve overall dental care practices.

Kebotix, Inc. is a company focused on revolutionizing the discovery and production of chemicals and materials through the integration of artificial intelligence, machine learning, and robotic automation. Established in 2017 and based in Cambridge, Massachusetts, Kebotix's platform significantly accelerates the research cycle, condensing it from years to months. This enables scientists to discover new materials and formulate products with specific desired properties more efficiently. The company's mission emphasizes enhancing public health and sustainability while promoting green chemistry solutions to eliminate hazardous substances. By providing access to its advanced digital research and development tools, Kebotix supports partners in materials innovation and development initiatives.

Acrobat Genomics is a company focused on drug discovery through innovative gene editing techniques. It employs high-throughput CRISPR technology to develop a range of new therapeutic options targeting various diseases. By utilizing its precision gene editing capabilities, Acrobat Genomics aims to enhance the availability of effective treatments, thereby supporting medical professionals in their efforts to improve patient care.

Valley creates a Digital Silicon Valley to assist users in creating, managing, and maximizing their startup communities. Users of Valley can create their startup stories, and the company shares the best ones with its investor network every two weeks via a newsletter that is sent to over 500 VCs and angel investors from companies like Sequoia, Antler, LAUNCH, NFX, and others.

Axoft is a company focused on developing advanced implantable electronics that enhance communication between the brain and machines. Its flagship technology consists of bioinspired implants made from ultra-flexible plastic mesh, which provides a softer alternative to traditional plastic and silicone implants. This innovative design allows for scalability and the integration of multiple sensors within a single implant, closely matching the brain's mechanical properties. Axoft's implants aim to improve clinical outcomes for patients suffering from neurodegenerative conditions, such as Parkinson's disease, thereby transforming individual health and overall human experience.

UneMeta is a curated social and NFT marketplace that focuses on established intellectual properties and icons. The company provides NFT incubation services, facilitating a transaction marketplace where users can engage socially. By offering a variety of gameplay options and IP resources, UneMeta aims to create a strong community foundation that supports NFT holders in securing web3 transactions. This platform combines social interaction with transactional capabilities, catering to the needs of users and enhancing their experience in the NFT space.

Finwave Semiconductor specializes in the development of advanced gallium nitride (GaN) transistors and integrated circuits (ICs) tailored for 5G communications and power conversion applications. The company utilizes a unique 3DGaN technology, specifically its differentiated fin field-effect transistor (FinFET) design, to enhance the performance of high-volume applications such as radio frequency front end (RFFE) systems for mobile devices. This innovative approach allows Finwave to create semiconductor materials with distinct properties, contributing to advancements in electronics and energy management.

Modern Synthesis is a biomaterial company focused on creating sustainable textiles for the fashion industry through innovative microbial weaving techniques. By harnessing the capabilities of bacteria, the company develops a new class of biobased textiles that offer significant advantages over traditional materials. These textiles provide strength and durability without the use of harmful petrochemical binders or toxic byproducts, and they eliminate the need for animal inputs, allowing for a diverse range of aesthetics to meet designers' needs. Modern Synthesis' technology utilizes bacterial nanocellulose, a highly versatile and robust form of cellulose, to produce customizable bio-textiles and composites. This approach not only replaces conventional materials such as animal leathers and plastic-based synthetics but also integrates efficiently with existing manufacturing practices, promoting scalability and sustainability within the industry.

Aspecta develops digital identity technology aimed at empowering individual developers and fostering ecosystem growth. The company offers a talent engine platform that utilizes artificial intelligence to enhance recruiting processes. This platform integrates extensive data related to web talent, allowing users to analyze millions of coding projects, technical posts, patents, and academic papers. By transforming both Web2 and Web3 footprints into AI-generated identities, Aspecta aims to revolutionize the potential of data within the digital identity landscape, providing valuable resources for builders and other stakeholders.

WeBox operates as a cloud kitchen focused on delivering authentic regional Asian cuisine while prioritizing health and quality. The company streamlines its cooking processes by utilizing advanced technology, including NSF-certified cooking robots, to enhance efficiency and maintain consistency in food preparation. WeBox emphasizes the use of high-quality ingredients, such as organic milk and eggs, Berkshire pork, and fresh live seafood, ensuring that its offerings are both healthy and flavorful. In addition to online food delivery, WeBox provides catering services, catering to a diverse range of customer preferences and promoting a savory dining experience.

Cache is a biotechnology company focused on developing a groundbreaking wet operating system designed for the storage, access, and computation of biomolecules at scale. By ensuring the integrity and fidelity of nucleic acids from various sources, Cache enables researchers and partners to accelerate molecular pathology research and gain insights into life sciences. This innovative approach facilitates the analysis of biomolecules, thereby unlocking new precision medicine applications and enhancing the capacity for understanding biological data. Ultimately, Cache aims to make both digital and biological data universally accessible and sustainable, eliminating the need for data deletion or disposal.

SanaHeal is a company focused on developing innovative bioadhesive biomaterials, including tapes, pastes, and powders, designed to bind tissues or organs. Its bioadhesive tapes serve as an alternative to traditional sutures, promoting healing while reducing complications following surgery. This technology aims to transform the treatment of wounds and bleeding, enhancing patient outcomes. Additionally, SanaHeal's platform offers mechanical integration solutions that assist in the care of patients with multiple traumatic injuries, ensuring they receive the necessary intensive care.

Regenerative Bio is a pioneering biotechnology company focused on anti-aging solutions through the integration of artificial intelligence and advanced computing technologies. The company is dedicated to researching and developing ingredients, formulations, and therapies aimed at mitigating the effects of aging and enhancing overall health. By leveraging AI, quantum physics, and high-throughput preparation methods, Regenerative Bio seeks to improve cellular health and energy metabolism, ultimately promoting longer, healthier lives. Their innovative approach combines pharmaceutical technology with biological research, addressing age-related health issues and contributing to the field of longevity science.

Revela is a direct-to-consumer company that discovers novel molecules for consumer health applications and creates better products using these new ingredients.

Kula Bio, Inc. is focused on developing innovative biological solutions for modern agriculture. Founded in 2018 and based in Somerville, Massachusetts, the company specializes in the production of organic biofertilizers using nitrogen-fixing microbes charged with renewable energy. By enhancing natural microbial processes, Kula Bio aims to create affordable and sustainable fertilization methods that enable farmers to increase their yields while promoting environmental stewardship. The company's approach seeks to disrupt traditional synthetic fertilizers, bridging the gap between effective agricultural practices and the responsible management of natural resources.

Velotric is a manufacturer of electric bicycles aimed at promoting a sustainable lifestyle with a smaller carbon footprint. The company offers e-bikes equipped with removable batteries, ensuring convenience for users. Velotric provides free shipping on all orders and includes a two-year warranty that covers bike frames, motors, batteries, and controllers for purchased units. Their electric bicycles are designed to be user-friendly, comfortable to ride, and high in performance, while also emphasizing reliability and stylish design. Through its products, Velotric seeks to facilitate a shift towards environmentally friendly transportation options and reduce harmful emissions.

Pantheon Design specializes in creating advanced 3D printing systems aimed at revolutionizing medium-scale manufacturing. The company focuses on developing flexible manufacturing solutions that cater to hardware innovators and integrators. Its printers are designed to deliver end-use quality parts significantly faster and at a lower cost compared to traditional methods. Pantheon Design's technology boasts industry-leading tolerances, superior surface finishes, and mechanical properties, ensuring that clients can produce high-quality products with ease and efficiency. By streamlining the manufacturing process, Pantheon Design addresses the common challenges faced by businesses in the production of parts, ultimately enhancing productivity and reducing costs.

Wetravel, Inc. operates an online platform designed to facilitate the organization and management of group trips, including dance tours, yoga retreats, and other multi-day travel experiences. Founded in 2014 and headquartered in San Francisco, California, the platform allows trip organizers to create customized booking pages in a matter of minutes. These pages enable users to promote trips, invite participants through social media and email, and manage financial transactions securely, collecting deposits and setting up payment plans. Wetravel supports various payment methods, including bank and credit card transactions, and offers features such as automatic image imports, traveler information collection, reviews, and post-trip surveys. The platform is particularly beneficial for travel companies and individuals organizing diverse travel experiences, as it streamlines logistics and enhances the overall planning process.

Snaplii is a digital wallet focused on transforming the North American fintech landscape by offering a comprehensive payment solution. The platform provides a range of services, including payment processing, lending, and card issuance, designed to enhance user experience. Snaplii features self-issued closed-loop digital credit cards that facilitate traditional payment functions while integrating innovative financial tools. This approach aims to assist merchants in increasing customer engagement and boosting sales through a unique membership and marketing program. By combining these functionalities, Snaplii positions itself as a valuable partner for businesses looking to drive traffic and improve consumer interaction.

EasyTransfer is a leading online tuition payment services platform designed specifically for international students and their families. Trusted by over 280,000 users, it processes more than $3 billion in transactions annually. The platform facilitates cross-border money transfers, making it easy for students to send and receive funds while studying abroad. EasyTransfer collaborates with notable partners such as Tencent, UnionPay, and Cashfree Payments, and is the exclusive international education payment service on WeChat. With a team of over 100 professionals fluent in various languages, the platform provides a user-friendly interface that allows for seamless transactions and real-time tracking of payments and compliance paperwork. Additionally, EasyTransfer employs advanced technology, including proprietary anti-money laundering systems, to ensure secure and efficient service, allowing transactions to be completed swiftly, often within an hour. The platform also offers a transparent bank market exchange rate with no markup, enhancing its appeal to users seeking reliable financial solutions for their educational needs.

Signet Therapeutics is a biopharmaceutical startup focusing on developing innovative targeted cancer drugs using novel disease models.

Citcon, founded in 2015 and headquartered in Silicon Valley, California, is a prominent payment technology company that facilitates mobile payments for global merchants. The company has developed a comprehensive platform that connects merchants with a wide array of mobile wallets and digital payment methods, enabling them to securely accept payments through web, mobile, and in-store channels. Citcon's infrastructure offers a user-friendly, contactless shopping experience that enhances security for both consumers and merchants. Through a single API suite and an integrated processing and fund settlement platform, businesses can efficiently manage domestic and international transactions. With a presence in the U.S., Canada, Europe, and Asia, Citcon serves millions of mobile wallet users, allowing them to shop at tens of thousands of participating merchants.

Sylvatica Biotech is focused on transforming organ transplantation, trauma care, oncofertility, and regenerative medicine through innovative cryopreservation technology. The company aims to develop a non-toxic method for banking human organs, which could address significant logistical challenges in organ preservation and enhance global organ matching. By utilizing strategies inspired by nature and integrating bioengineering principles, Sylvatica seeks to improve the longevity and viability of stored organs, potentially saving millions of lives each year. This advancement is anticipated to yield public health benefits comparable to those achieved through significant medical breakthroughs, such as curing cancer. Sylvatica's work has garnered recognition, being highlighted as a success story by the National Institutes of Health.

ZSFab, Inc. is a company based in Cambridge, Massachusetts, that specializes in the manufacturing and supply of customized medical implants and surgical guides. Founded in 2017, ZSFab focuses on providing patient-specific solutions through advanced 3D printing technology. The company produces a range of products, including hip implants, acetabular cups, vertebral body implants, and anatomical models. By utilizing biocompatible materials and optimizing modeling processes, ZSFab aims to enhance surgical precision, thereby reducing surgery time and improving patient recovery outcomes. Their innovative approach supports surgeons in delivering more effective care, contributing to lower malpractice rates and better overall patient experiences.

XtalPi Inc. is a pharmaceutical technology company that focuses on digital drug development solutions, leveraging quantum mechanics and artificial intelligence to enhance the efficiency of drug research and development. Founded in 2014 by a group of quantum physicists at MIT, the company has developed its Intelligent Digital Drug Discovery and Development (ID4) platform, which integrates advanced cloud computing algorithms to aid pharmaceutical firms in critical stages of drug R&D. XtalPi offers various tools, including XtalForc for visual force field calculations, XtalVision for crystal structure predictions, and Renova for platform support of its AI research initiatives. Its comprehensive services encompass crystal structure determination, solid-state testing, small molecule drug design, and collaborations in antibody and peptide research. Based in Cambridge, Massachusetts, with additional offices in China, XtalPi has established strategic partnerships with leading international pharmaceutical companies, demonstrating the broad applicability and recognition of its innovative technologies across the pharmaceutical value chain.

Nirvana is an AI-native financial infrastructure shaping the future of Agentic DeFi. - Redefining DeFi with AI Agents – Nirvana builds AI frameworks for DEFAI agents to maximize capital efficiency - AI-Native On-Chain Protocols – Empowering DEFAI agents with AI-native protocols to autonomously launch innovative financial instruments and optimize strategies

Relativity Space is an aerospace company based in Long Beach, California, that designs, develops, and manufactures 3D-printed rockets. Founded in 2015, the company aims to revolutionize rocket production through a vertically integrated technology platform that combines 3D printing, artificial intelligence, and autonomous robotics. This innovative approach allows for a significantly simplified supply chain, enabling the production of rockets with 100 times fewer parts in less than 60 days. In addition to manufacturing rockets, Relativity Space provides comprehensive services for satellite production, testing, and launching. The company is supported by prominent investors, highlighting its potential in the rapidly evolving aerospace sector.

Bioz Inc. is a technology company that has developed a cloud-based platform utilizing natural language processing (NLP) and artificial intelligence (AI) to aid scientific researchers in the life sciences. Founded in 2013 and based in Palo Alto, California, Bioz offers a search engine that allows life scientists in academia and biopharma to efficiently find, compare, and select the appropriate reagents, instruments, and consumables for their experiments. The platform includes features such as full-text analysis, relevancy ranking, and a product rating system, all designed to enhance the research process. By analyzing data from the materials and methods sections of peer-reviewed articles, Bioz helps researchers identify key insights and correlations, ultimately accelerating scientific discovery and increasing the likelihood of successful outcomes in drug development and disease treatment.

ProteoWise Inc., founded in 2018 and based in Branford, Connecticut, specializes in the development of innovative proteomics instruments. The company has created a unique 3-dimensional nanoscale protein capturing material that significantly enhances the analysis of proteins, enabling researchers to conduct experiments more easily and efficiently. ProteoWise's technology simplifies the traditional western blot method, providing a combination of high information content, high throughput, and low cost. This advancement is instrumental in driving the genomic revolution and supports the growing demands of proteomics research. The company was established by a team of experienced scientists from the Strittmatter Lab at Yale University, who bring a strong history of innovation to the field.

Databento offers a streamlined platform for accessing financial market data, founded by professionals with backgrounds in trading and engineering from leading quantitative hedge funds. The company provides a self-service model that allows users to access live exchange feeds and vast amounts of historical data efficiently. Clients can choose between a pay-as-you-go system or flat-rate pricing, providing flexibility based on their needs. By hosting servers in colocation facilities at various trading venues, Databento ensures low-latency and high-fidelity data capture directly from the source. Its platform also automates data licensing and reduces onboarding time, making it easier for businesses and financial institutions to obtain reliable, institutional-grade data while minimizing storage costs.

Cardea Bio, Inc. is a biotechnology company based in San Diego, California, focused on developing and commercializing bioelectronics for research and diagnostics. Established in 2013, Cardea utilizes proprietary graphene-based digital biosensors to create advanced biosensor hardware, software, and molecular infrastructure, enabling precision healthcare through improved diagnostic capabilities. The company's product offerings include the AGILE R100, an innovative assay for drug discovery, and the AGILE R200, an automated high-throughput screening solution. Cardea's biosensors convert biomolecular interactions into digital data, allowing for real-time biological signal analysis and access to streaming multi-omics data. Their solutions cater to various applications in life sciences and healthcare, such as small molecule validation, antibody characterization, and biomolecular analysis.

SnapPay is a prominent North American payment platform that facilitates the acceptance of Alipay, WeChat Pay, and China UnionPay for merchants. By enabling secure online, in-store, in-app, and mobile transactions, SnapPay streamlines payment processes for both consumers and businesses. Additionally, the platform offers marketing solutions that assist merchants in reaching new customers and increasing their revenue streams, both online and offline. With a focus on providing simple and secure one-touch payment services, SnapPay enhances the customer experience and supports the growth of businesses in the competitive e-commerce landscape.

Hyperloop One, Inc. is focused on the design and development of a high-speed tubular transit system that employs magnetic levitation technology to facilitate the rapid transportation of passengers and cargo. Founded in 2014 and headquartered in Los Angeles, California, the company aims to provide direct and sustainable transportation solutions. Hyperloop One's innovative system allows for speeds of up to 760 miles per hour, utilizing a vacuum tube to optimize travel efficiency. The company collaborates with various partners, including renowned firms such as Parsons, ARUP, and McKinsey, to enhance its technology and implementation strategies. Originally known as Hyperloop Technologies, Inc., the company rebranded in May 2016 to reflect its evolving mission within the transportation sector.

TheraDep specializes in the development of surface coatings for microneedles and labware, targeting the medical device and pharmaceutical sectors. The company creates biocompatible coatings that are drug-eluting, growth-promoting, and therapeutic, utilizing a patented process to meet the specific requirements of its clients. By collaborating with medical device and labware manufacturers, TheraDep aims to deliver innovative drug delivery solutions that enhance patient treatment outcomes.

Landsdowne is a developer focused on innovative battery technology, specifically designed to address the health risks associated with button batteries. The company is commercializing a solution that deactivates batteries after accidental ingestion, aiming to provide a safe alternative for international businesses. Landsdowne's products not only target the growing health crisis related to button batteries but also include materials for injury prevention, ensuring that vulnerable individuals, such as those with fragile skin, are protected. By offering a turnkey, cost-effective solution, Landsdowne seeks to enhance safety and mitigate the risks posed by button batteries in various applications.

OnePiece Work is a global tech community that provides coworking spaces designed to foster collaboration and innovation across various industries. Founded with the mission of creating an inclusive environment, OnePiece Work aims to enhance personal and professional growth, particularly for minority professionals facing challenges in workplace culture. The company offers flexible workspace services, including meeting rooms and comfortable workstations, along with strategic consultation and investment services to support startups in their development. With partnerships spanning over 250 companies and 30 industries, OnePiece Work has established itself as a hub for creativity and collaboration, where individuals and businesses can thrive together.

Enrich Biosystems focuses on developing innovative technologies for cell imaging, analysis, and capture, aimed at advancing cell-based therapies and precision medicine. The company has created a unique single-cell isolation platform that operates without microfluidics, utilizing dissolvable microwells and visual enrichment techniques. This approach addresses significant challenges faced by existing technologies, offering a streamlined workflow for cell culturing and kinetics profiling. Enrich Biosystems' solutions enhance biomedical research by allowing healthcare professionals to efficiently capture and analyze individual cells based on their functions, thereby facilitating progress in various critical life science applications.

MuMec, Inc. is a fabless startup based in Oakland, California, founded in 2014, specializing in the development of wireless transceiver technologies. The company focuses on creating solutions that significantly lower operating power for devices utilizing Bluetooth low energy and LoRa/Sigfox protocols. By enabling continuous operation of sensor node devices for extended periods—often using scavenged or battery power—MuMec's transceivers cater to various applications, including wireless audio streaming and Internet of Things (IoT) devices. Their innovations aim to enhance energy efficiency, allowing consumers to reduce power consumption and extend the battery life of various electronic devices.

New Frontier Bio is a biotechnology company established in 2020 and based in Beverly, Massachusetts. The company focuses on developing consumer health products aimed at reversing the signs of aging and enhancing natural health and lifespan at a cellular level. Its product offerings include skin health solutions and dietary supplements that utilize a natural compound known for promoting skin longevity. By addressing the effects of aging, New Frontier Bio seeks to improve the quality of life for consumers.

AltrixBio, Inc. is a biotechnology company based in Cambridge, Massachusetts, established in 2019. It focuses on developing therapeutic drugs for controlled gastrointestinal targeting, primarily addressing Type 2 diabetes and obesity. The company's flagship product, LuCI™, is an oral medication designed to mimic the effects of gastric bypass surgery by providing duodenal isolation. This innovative approach aims to replicate the metabolic benefits of bariatric surgery, offering a more accessible and cost-effective treatment option for patients. AltrixBio's mission centers on improving health outcomes for individuals facing challenges related to obesity and its associated conditions.

Concerto Biosciences specializes in rebuilding microbial communities to enhance human health and environmental sustainability. The company has developed an ultra-high-throughput platform capable of measuring millions of microbial interactions, enabling the mapping of complex inter-species networks that dictate community behavior. This innovation allows Concerto to create "ensembles," which are specific combinations of microbes that collaboratively promote the recovery of damaged microbial ecosystems. By focusing on these microbial ensembles, Concerto aims to address critical global issues across various sectors, including agriculture, healthcare, and industry. The company's pioneering work positions it as a leader in the development of microbial solutions, fundamentally changing how humanity interacts with microbial life.

Manus Bio Inc. is a biotechnology company that specializes in recreating plant processes in microorganisms to produce natural ingredients through advanced fermentation technology. Founded in 2011 and based in Cambridge, Massachusetts, the company utilizes a combination of metabolic engineering, protein engineering, and systems biology to develop microbes capable of generating a variety of plant-based ingredients. These ingredients have diverse applications, including flavors, fragrances, food ingredients, cosmetics, vitamins, pharmaceuticals, and agricultural chemicals. Manus Bio operates manufacturing facilities in Cambridge and Augusta, Georgia, and has established a strategic partnership with BBGI Public Company Limited. The company was previously known as Manus Biosynthesis, Inc. before changing its name in June 2018.

Pointcloud is a developer of a 3D imaging platform that utilizes advanced technology for big data analytics on 3D point clouds, leveraging machine learning. The company's innovations are aimed at enhancing applications in augmented reality, robotics, and autonomous mobility, facilitating clearer and more effective visualization of the environment. By focusing on high-performance 4D imaging, Pointcloud positions itself at the forefront of emerging technologies that are set to transform various industries.

Cardea Bio, Inc. is a biotechnology company based in San Diego, California, focused on developing and commercializing bioelectronics for research and diagnostics. Established in 2013, Cardea utilizes proprietary graphene-based digital biosensors to create advanced biosensor hardware, software, and molecular infrastructure, enabling precision healthcare through improved diagnostic capabilities. The company's product offerings include the AGILE R100, an innovative assay for drug discovery, and the AGILE R200, an automated high-throughput screening solution. Cardea's biosensors convert biomolecular interactions into digital data, allowing for real-time biological signal analysis and access to streaming multi-omics data. Their solutions cater to various applications in life sciences and healthcare, such as small molecule validation, antibody characterization, and biomolecular analysis.

Butlr is a technology studio based in downtown San Francisco that specializes in developing software and AI-based solutions. The company focuses on an AI people-sensing platform that utilizes body heat to detect occupancy, headcount, body posture, and activity, providing real-time and historical spatial insights primarily for the healthcare and sustainable building sectors. Butlr's innovative sensor technology anonymously detects human presence through low-resolution thermal data combined with advanced AI and machine learning techniques. With a streamlined approach to product development, Butlr typically completes build cycles in about six weeks, allowing the team to assess market traction and viability efficiently. The company has successfully launched multiple products, continuously seeking opportunities for growth and improvement in its offerings.

Galixir is a U.S.-based company founded in 2019 that specializes in artificial intelligence technology for drug research and development. The company provides a comprehensive platform that assists pharmaceutical firms in various stages of drug development, including retrosynthesis prediction, synthetic design, drug screening, and molecular design. By integrating advanced methodologies from engineering chemistry, computational chemistry, and computational biology, Galixir aims to streamline the drug discovery process, significantly reducing both time and costs for researchers. Additionally, its platform includes features for patent protection, ensuring that the developed drugs are safeguarded. Through its innovative approach, Galixir addresses the complexities of drug development, making it more efficient for clients in the pharmaceutical industry.

Kula Bio, Inc. is focused on developing innovative biological solutions for modern agriculture. Founded in 2018 and based in Somerville, Massachusetts, the company specializes in the production of organic biofertilizers using nitrogen-fixing microbes charged with renewable energy. By enhancing natural microbial processes, Kula Bio aims to create affordable and sustainable fertilization methods that enable farmers to increase their yields while promoting environmental stewardship. The company's approach seeks to disrupt traditional synthetic fertilizers, bridging the gap between effective agricultural practices and the responsible management of natural resources.

LASE Innovation Inc. is an early-stage startup based in Cambridge, Massachusetts, focused on developing and commercializing advanced laser particle technology. Founded in 2018, the company specializes in light-emitting particles ranging from nano to micron sizes, primarily targeting the life sciences and diagnostic markets. Its innovative technology utilizes billions of spectral barcodes for massively multiplexed tagging and imaging of single cells, significantly enhancing the capabilities of conventional fluorescent probes for applications such as multiplexing and cell tracking. LASE Innovation aims to provide optics solutions that enable researchers to achieve unprecedented levels of precision and efficiency in their work.

BluWhale is a United States-based company that specializes in artificial intelligence solutions for business intelligence software as a service (SaaS) platforms. The company focuses on automating LiveOps and optimizing revenue, thereby enabling game developers to concentrate on enhancing their games instead of managing large volumes of data. By utilizing AI and machine learning, BluWhale's smart automation handles tasks typically performed by data analysts and data scientists, providing actionable insights that facilitate informed decision-making.